Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Must-Buy Real Estate Stocks to Invest In

In this article, we will look at the 10 Must-Buy Real Estate Stocks to Invest In.

Real estate stocks have been returning to the radar of investors after a period where rising interest rates weighed heavily on the sector. Higher borrowing costs compressed property valuations and pressured REIT share prices across much of the past two years. However, as property fundamentals show signs of resilience, investors are increasingly revisiting listed real estate for both income and long-term capital appreciation. Publicly traded real estate companies also provide an accessible way to gain exposure to property markets without directly owning physical assets, which becomes appealing when valuations begin to look more attractive relative to broader equities.

Institutional investors have started to highlight improving prospects for the sector. Invesco notes that listed real estate currently offers a “compelling combination of improving fundamentals, attractive valuations, and sector-specific opportunities.” The firm adds that the “overall outlook for REITs is constructive,” suggesting that public real estate markets may benefit investors who begin to reassess the sector’s earnings stability and income profile. Cohen & Steers expresses a similar view in its real assets outlook, stating that its macroeconomic outlook remains “constructive for real assets” as economic activity and market returns broaden across sectors. These perspectives suggest that after lagging during the rate hiking cycle, listed real estate may be entering a period where both income and price performance begin to stabilize.

With valuations still recovering and institutional investors pointing to improving fundamentals across parts of the property market, we take a closer look at the 10 Must-Buy Real Estate Stocks to Invest In.

Our Methodology

We used screeners to identify real estate stocks that have an upside potential of at least 20% and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

10. American Homes 4 Rent (NYSE:AMH)

On March 13, 2026, Mizuho analyst Haendel St. Juste lowered the price target on American Homes 4 Rent (NYSE:AMH) to $29 from $32 and maintained a Neutral rating after updating estimates for the company.

On March 9, 2026, Morgan Stanley lowered its price target on AMH to $39 from $40 and maintained an Overweight rating as the firm updated models following Q4 earnings and 2026 guidance. On March 6, 2026, Barclays lowered its price target on AMH to $31 from $33 and maintained an Equal Weight rating after reducing estimates across the residential real estate investment trust sector.

Last month, AMH reported Q4 core FFO of 47c, in line with the 47c consensus estimate. Revenue totaled $454.99M compared with the $458.98M consensus estimate. CEO Bryan Smith said housing affordability remains under pressure and described the company as “part of the solution,” referring to its effort to expand housing choice and supply. Smith added that the company’s ground-up development program has contributed more than 14,000 newly built homes to the U.S. housing stock while AMH continues focusing on improving the resident experience.

Earlier in February, the board of trustees declared a quarterly dividend of 33c per share for the first quarter of 2026, representing a 10% increase from the prior quarterly dividend of 30c.

American Homes 4 Rent (NYSE:AMH) develops, renovates, leases, and manages single-family rental homes in the United States.

9. Alexandria Real Estate Equities, Inc. (NYSE:ARE)

On March 10, 2026, JPMorgan lowered the price target on Alexandria Real Estate Equities, Inc. (NYSE:ARE) to $57 from $63 and maintained a Neutral rating after updating the firm’s model.

Last month, Morgan Stanley lowered its price target on Alexandria Real Estate Equities, Inc. (NYSE:ARE) to $54 from $55 and maintained an Equal Weight rating after revising its 2026 FFO estimate. Goldman Sachs also initiated coverage of ARE with a Neutral rating and a $60 price target. Goldman described the company’s assets as “high-quality” but said they face “systemic pressures” tied to the U.S. life science industry. The firm’s lab demand model points to an “extended and gradual” recovery, with net absorption expected to turn sustainably positive only in 2027, suggesting a longer timeline for tenant demand to rebound.

Earlier, Alexandria Real Estate Equities, Inc. (NYSE:ARE) reported Q4 FFO of $2.16 versus consensus of $2.15. Revenue came in at $754.14M compared with the $742.64M consensus estimate. The company reaffirmed its FY26 adjusted FFO outlook of $6.25 to $6.55, versus consensus of $6.42, and expects FY26 same-property NOI of (9.5%) to (7.5%). ARE said guidance reflects its current view of market conditions but remains subject to variables including leasing velocity, tenant demand, and policy developments affecting life science funding and regulation.

Alexandria Real Estate Equities, Inc. (NYSE:ARE) is a life science real estate investment trust focused on owning and developing laboratory and research campuses.

8. CBRE Group, Inc. (NYSE:CBRE)

On March 13, 2026, Barclays lowered the price target on CBRE Group, Inc. (NYSE:CBRE) to $174 from $192 and maintained an Overweight rating, citing weaker investor sentiment across the commercial real estate services group.

On February 23, 2026, UBS upgraded CBRE to Buy from Neutral and raised its price target to $185 from $175. UBS described the recent pullback in the shares as a “rare buying opportunity,” pointing to CBRE’s “strong industry position and vast data assets” as advantages even as AI could shape the sector over time. The firm raised estimates following company guidance and said industry conditions in commercial real estate continue to improve.

Earlier in February, CBRE reported Q4 core EPS of $2.73 versus the $2.68 consensus estimate. Revenue totaled $11.6B compared with the $11.62B consensus estimate. Chair and CEO Bob Sulentic said the company finished the year with “a strong end to 2025,” noting that both revenue and core EPS rose by double digits in the fourth quarter. Sulentic pointed to gains in sales and leasing across the U.S. and many international markets while the company’s more resilient business lines continued posting double-digit revenue growth.

CBRE Group, Inc. (NYSE:CBRE) operates as a commercial real estate services and investment company through its Advisory Services, Building Operations and Experience, Project Management, and Real Estate Investments segments.

7. Cushman & Wakefield Limited (NYSE:CWK)

On March 13, 2026, Barclays analyst Brendan Lynch lowered the price target on Cushman & Wakefield Limited (NYSE:CWK) to $15 from $19 and maintained an Equal Weight rating, citing weaker investor sentiment across the commercial real estate services group.

On February 27, 2026, Goldman Sachs lowered its price target on Cushman & Wakefield Limited (NYSE:CWK) to $19.50 from $22.25 and maintained a Buy rating.

On February 19, 2026, Cushman & Wakefield Limited (NYSE:CWK) reported Q4 adjusted EPS of 54c, in line with the 54c consensus estimate. Revenue came in at $2.91B compared with the $2.83B consensus estimate. CEO Michelle MacKay said the quarter capped an “exceptional year,” noting that adjusted EPS grew 34% in 2025 while the company improved cash flow by more than $125M and prepaid $300M in debt. MacKay added that commercial real estate end markets remain healthy with solid demand across major asset classes and improving pricing and liquidity as the company enters 2026 focused on executing its long-term strategic priorities.

Cushman & Wakefield Limited (NYSE:CWK) provides commercial real estate services across the Americas, Europe, the Middle East, Africa, and Asia Pacific.

6. Cousins Properties Incorporated (NYSE:CUZ)

On March 12, 2026, BMO Capital lowered the price target on Cousins Properties Incorporated (NYSE:CUZ) to $27 from $31 and maintained an Outperform rating. BMO noted the REIT’s shares trade at a 36% discount to its COVID-era FFO multiple despite rising occupancy and stronger leasing activity, adding that the company could continue benefiting from a flight-to-quality trend in its Sunbelt markets.

On February 26, 2026, Barclays lowered its price target on CUZ to $28 from $34 and maintained an Overweight rating after updating models across the office real estate investment trust group following Q4 reports. Barclays said the “AI disruption narrative” is likely to continue weighing on office valuations.

Earlier in February, CUZ reported Q4 FFO of 71c, in line with the 71c consensus estimate. Revenue totaled $255.03M compared with the $251.49M consensus estimate. CEO Colin Connolly said “improving office fundamentals” is creating tailwinds for the company, noting that Cousins executed 700,000 square feet of leases during the quarter and has a late-stage pipeline of roughly 1.1 million square feet. Connolly also pointed to the recent acquisition of 300 South Tryon in Uptown Charlotte and said the company has purchased $1.4B of lifestyle office properties over the past six quarters, helping upgrade its Sun Belt portfolio and support its 2026 earnings outlook.

Cousins Properties Incorporated (NYSE:CUZ) is a real estate investment trust focused on Class A office buildings in high-growth Sun Belt markets.

While we acknowledge the potential of CUZ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CUZ and that has 100x upside potential, check out our report about this cheapest AI stock.

Click to continue reading and see the 5 Must-Buy Real Estate Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.